Trials / Terminated
TerminatedNCT02207582
Prefrontal Transcranial Random Noise Stimulation in Patients With Depression
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- University of Regensburg · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Transcranial random noise stimulation is used to stimulate the prefrontal cortices in patients with depression. It's a placebo-controlled two-arm study.
Detailed description
Transcranial random noise stimulation (tRNS) is a non-invasive electric stimulation technique of the brain which was shown to be superior effective in contrast to other electric stimulation such as transcranial direct current stimulation (tDCS). These studies investigated mainly healthy controls and specific tasks. Only one case report is available for depression. Here we stimulate patients with depression with tRNS in a placebo-controlled two-arm design. Stimulation will be done as add-on to standard therapy. Electrodes will be applied over both dorsolateral prefrontal cortices which are standard target points of tDCS and also transcranial magnetic stimulation in depression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Verum Prefrontal tRNS | 2mA of tRNS (DC-Stimulator, NeuroConn GmbH, Germany) with a zero offset will be applied to the left and right dorsolateral prefrontal cortex. Treatment will consist of 15 days with 20 minutes stimulation per day. Voltage will be ramped at the begin and end of a stimulation for 10 seconds. |
| DEVICE | Placebo Prefrontal tRNS | 2mA of tRNS (DC-Stimulator, NeuroConn GmbH, Germany) with a zero offset will be applied to the left and right dorsolateral prefrontal cortex. Treatment will consist of 15 days with 20 minutes stimulation per day. Voltage will be ramped at the begin and end of a stimulation for 10 seconds. Placebo stimulation will consist of just applying the ramps at the begin and end of the stimulation. |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2016-10-14
- Completion
- 2016-12-06
- First posted
- 2014-08-04
- Last updated
- 2018-06-18
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02207582. Inclusion in this directory is not an endorsement.